For research use only. Not for therapeutic Use.
Valiloxibic acid（Cat No.:I037943）is a prodrug derivative designed to improve the pharmacokinetic properties and delivery of active oxazolidinone antibiotics, such as linezolid. It incorporates a valine ester moiety to enhance oral bioavailability and stability, facilitating effective absorption and subsequent conversion to the active drug. Valiloxibic acid aims to treat bacterial infections, including those caused by multidrug-resistant Gram-positive pathogens like MRSA and VRE. By optimizing drug delivery and systemic exposure, it offers potential advantages in dosing convenience, therapeutic efficacy, and reduced side effects in the management of serious bacterial infections.
| CAS Number | 238401-16-6 |
| Synonyms | 4-[(2S)-2-amino-3-methylbutanoyl]oxybutanoic acid |
| Molecular Formula | C9H17NO4 |
| Purity | ≥95% |
| IUPAC Name | 4-[(2S)-2-amino-3-methylbutanoyl]oxybutanoic acid |
| InChI | InChI=1S/C9H17NO4/c1-6(2)8(10)9(13)14-5-3-4-7(11)12/h6,8H,3-5,10H2,1-2H3,(H,11,12)/t8-/m0/s1 |
| InChIKey | RMGPNQKZEPTAOC-QMMMGPOBSA-N |
| SMILES | CC(C)[C@@H](C(=O)OCCCC(=O)O)N |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
